Breaking News Instant updates and real-time market news.

AKCA

Akcea Therapeutics

$34.33

0.64 (1.90%)

07:52
08/07/18
08/07
07:52
08/07/18
07:52

Akcea Therapeutics transferred with a Hold at Stifel

Stifel transferred coverage of Akcea Therapeutics to analyst Paul Matteis, who set a Hold rating and $33 price target on the shares. His enthusiasm for their LICA antisense pipeline is balanced by his view that upcoming launches for Tegsedi in TTR Amyloidosis and Walyirva in Familial Chylomicronemia Syndrome could be below consensus, Matteis tells investors.

  • 30

    Aug

  • 06

    Oct

AKCA Akcea Therapeutics
$34.33

0.64 (1.90%)

05/11/18
WELS
05/11/18
UPGRADE
WELS
Outperform
Akcea Therapeutics upgraded to Outperform from Market Perform at Wells Fargo
05/11/18
STFL
05/11/18
NO CHANGE
Target $25
STFL
Hold
Akcea clarity improved by panel vote, but challenges remain, says Stifel
Stifel analyst Stephen Willey said the FDA Advisory Committee's vote in favor of supporting the approval of volanesorsen improves the regulatory clarity for Akcea Therapeutics, but he believes commentary from both voting members and FDA reviewers would suggest there's still "tangible risk" to the formal FDA decision due on August 30. He has reduced his peak worldwide sales estimates to approximately $200M in an effort to better reflect the high proportion of patient discontinuations and dose-reductions occurring within clinical development, which lowered his price target on Akcea shares to $25 from $30. Willey keeps a Hold rating on the stock.
05/11/18
WELS
05/11/18
UPGRADE
Target $33
WELS
Outperform
Akcea upgraded to Outperform with $33 target at Wells Fargo
Wells Fargo analyst Jim Birchenough upgraded Akcea Therapeutics to Outperform from Market Perform after an FDA panel voted 12-8 to support approval of Waylivra for the treatment of people with familial chylomicronemia syndrome. The analyst expects the vote to support approval of the drug by the August 30 action date. He raised his price target for Akcea shares to $33 from $30.
07/11/18
PIPR
07/11/18
NO CHANGE
Target $50
PIPR
Neutral
Ionis approval narrower than expected, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren says the European approval of Tegsedi announced this morning Ionis Pharmaceuticals (IONS) and Akcea Therapeutics (AKCA) for the treatment of stage 1 or stage 2 polyneuropoathy in adult patients with hATTR was narrower than he originally expected. The indication is narrower than the broader hATTR patient population, inclusive of both cardiomyopathy and polyneuropathy, but makes sense considering that the pivotal trial primarily enrolled patients with stage 1 and 2 polyneuropathy, Van Buren tells investors in a research note. The analyst adds that while the approval is a positive development and Tegsedi represents the largest near-term pipeline opportunity for Ionis, he wants to observe positive early launch metrics and confirmation of the opportunity before getting more constructive on the shares. He keeps a Neutral rating on Ionis with a $50 price target.

TODAY'S FREE FLY STORIES

SA

Seabridge Gold

$11.74

-0.21 (-1.76%)

15:34
11/13/18
11/13
15:34
11/13/18
15:34
Options
Seabridge Gold options imply 5.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBBN

Ribbon Communications

$4.98

-1.66 (-25.00%)

15:32
11/13/18
11/13
15:32
11/13/18
15:32
Hot Stocks
Breaking Hot Stocks news story on Ribbon Communications »

Ribbon Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$132.00

0.49 (0.37%)

, AAPL

Apple

$193.20

-0.955 (-0.49%)

15:27
11/13/18
11/13
15:27
11/13/18
15:27
Periodicals
Spotify launches Apple Watch app, missing major features, Gizmodo says »

After months of rumors…

SPOT

Spotify

$132.00

0.49 (0.37%)

AAPL

Apple

$193.20

-0.955 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

BL

BlackLine

$40.64

-0.01 (-0.02%)

15:25
11/13/18
11/13
15:25
11/13/18
15:25
Conference/Events
BlackLine to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

NEPT

Neptune Wellness

$3.31

-0.03 (-0.90%)

15:19
11/13/18
11/13
15:19
11/13/18
15:19
Options
Neptune Technologies options imply 19.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
11/13/18
11/13
15:17
11/13/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$15.73

-4.1 (-20.68%)

15:16
11/13/18
11/13
15:16
11/13/18
15:16
Recommendations
Amarin analyst commentary  »

Physicians not concerned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
11/13/18
11/13
15:16
11/13/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$179.85

0.34 (0.19%)

15:16
11/13/18
11/13
15:16
11/13/18
15:16
Recommendations
Home Depot analyst commentary  »

Home Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

FB

Facebook

$142.51

0.99 (0.70%)

15:11
11/13/18
11/13
15:11
11/13/18
15:11
Hot Stocks
Facebook took down 141 accounts following FBI tip »

Facebook said that last…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

THC

Tenet

$23.33

-2.39 (-9.29%)

15:10
11/13/18
11/13
15:10
11/13/18
15:10
Options
$2M call buy in Tenet Healthcare as shares lose 9% »

$2M call buy in Tenet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

15:10
11/13/18
11/13
15:10
11/13/18
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

AMC

AMC Entertainment

$15.49

0.3 (1.98%)

15:08
11/13/18
11/13
15:08
11/13/18
15:08
Recommendations
AMC Entertainment analyst commentary  »

AMC seeing success with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 04

    Dec

AAWW

Atlas Air

$55.19

2.03 (3.82%)

15:05
11/13/18
11/13
15:05
11/13/18
15:05
Hot Stocks
Atlas Air, Southern Air announce pathway program agreement with Ameriflight »

Atlas Air Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIX

Wix.com

$90.46

1.99 (2.25%)

15:04
11/13/18
11/13
15:04
11/13/18
15:04
Options
Wix.com options imply 18.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

ECA

Encana

$8.10

-0.31 (-3.69%)

15:00
11/13/18
11/13
15:00
11/13/18
15:00
Options
Encana option volume hits year high as shares touch year lows »

Encana option volume hits…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRVO

Qorvo

$63.45

-0.35 (-0.55%)

, AAPL

Apple

$193.43

-0.725 (-0.37%)

14:51
11/13/18
11/13
14:51
11/13/18
14:51
Recommendations
Qorvo, Apple, Lumentum, Skyworks, Cirrus Logic, Broadcom analyst commentary  »

After Qorvo warns, MKM…

QRVO

Qorvo

$63.45

-0.35 (-0.55%)

AAPL

Apple

$193.43

-0.725 (-0.37%)

LITE

Lumentum

$38.92

1.415 (3.77%)

SWKS

Skyworks

$72.16

-0.61 (-0.84%)

CRUS

Cirrus Logic

$37.63

1.99 (5.58%)

AVGO

Broadcom

$224.39

0.84 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 19

    Nov

  • 06

    Dec

QRVO

Qorvo

$63.36

-0.44 (-0.69%)

, AAPL

Apple

$193.50

-0.655 (-0.34%)

14:51
11/13/18
11/13
14:51
11/13/18
14:51
Recommendations
Qorvo, Apple analyst commentary  »

JPMorgan sees…

QRVO

Qorvo

$63.36

-0.44 (-0.69%)

AAPL

Apple

$193.50

-0.655 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

AMRS

Amyris

$6.05

0.19 (3.24%)

14:49
11/13/18
11/13
14:49
11/13/18
14:49
Options
Amyris options imply 19.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

BA

Boeing

$347.91

-9.02 (-2.53%)

14:46
11/13/18
11/13
14:46
11/13/18
14:46
Periodicals
Pilots claim Boeing Lion Air crash linked to improper training, FT reports »

Pilot associations said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$193.31

-0.845 (-0.44%)

14:45
11/13/18
11/13
14:45
11/13/18
14:45
Technical Analysis
Technical Take: Apple moves lower after rally fails »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

XLK

Technology Select Sector SPDR

$67.49

0.08 (0.12%)

14:40
11/13/18
11/13
14:40
11/13/18
14:40
Options
Aggressive call buying in SPDR Tech Fund »

Aggressive call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRVO

Qorvo

, AAPL

Apple

$192.80

-1.355 (-0.70%)

14:37
11/13/18
11/13
14:37
11/13/18
14:37
Recommendations
Qorvo, Apple analyst commentary  »

Qorvo price target…

QRVO

Qorvo

AAPL

Apple

$192.80

-1.355 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

TEUM

Pareteum

$1.87

-0.26 (-12.21%)

, IPAS

iPass

$1.14

(0.00%)

14:37
11/13/18
11/13
14:37
11/13/18
14:37
Recommendations
Pareteum, iPass analyst commentary  »

Pareteum price target…

TEUM

Pareteum

$1.87

-0.26 (-12.21%)

IPAS

iPass

$1.14

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

CF

CF Industries

$50.26

-1.03 (-2.01%)

14:35
11/13/18
11/13
14:35
11/13/18
14:35
Options
CF Industries put volume heavy and directionally bearish »

Bearish flow noted in CF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.